RGH188 hydrochloride
| Title | Journal |
|---|---|
| Cariprazine: First Global Approval. | Drugs 20151101 |
| Cariprazine: chemistry, pharmacodynamics, pharmacokinetics, and metabolism, clinical efficacy, safety, and tolerability. | Expert opinion on drug metabolism & toxicology 20130201 |
| Discovery of cariprazine (RGH-188): a novel antipsychotic acting on dopamine D3/D2 receptors. | Bioorganic & medicinal chemistry letters 20120515 |
| Occupancy of dopamine D₂ and D₃ and serotonin 5-HT₁A receptors by the novel antipsychotic drug candidate, cariprazine (RGH-188), in monkey brain measured using positron emission tomography. | Psychopharmacology 20111201 |
| Cariprazine (RGH-188), a potent D3/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and procognitive effects in rodents. | Neurochemistry international 20111101 |
| In vitro pharmacology of aripiprazole, its metabolite and experimental dopamine partial agonists at human dopamine D2 and D3 receptors. | European journal of pharmacology 20111015 |
| Pharmacokinetics and metabolism update for some recent antipsychotics. | Expert opinion on drug metabolism & toxicology 20110701 |
| [The dopamin D3 receptor--the gray eminence of pharmacotherapy?]. | Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology 20100901 |
| Cariprazine, an orally active D2/D3 receptor antagonist, for the potential treatment of schizophrenia, bipolar mania and depression. | Current opinion in investigational drugs (London, England : 2000) 20100701 |
| Cariprazine (RGH-188), a dopamine D(3) receptor-preferring, D(3)/D(2) dopamine receptor antagonist-partial agonist antipsychotic candidate: in vitro and neurochemical profile. | The Journal of pharmacology and experimental therapeutics 20100401 |